Wockhardt informs about press release

01 Dec 2025 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has enclosed Press Release - ‘US FDA Accepts Wockhardt’s New Drug Application for Breakthrough Antibiotic Zaynich’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1356.05 24.70 (1.86%)
05-Dec-2025 11:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.05
Dr. Reddys Lab 1279.65
Cipla 1519.85
Zydus Lifesciences 932.50
Lupin 2097.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×